2023/0491 - RIBOCICLIB [200 MG CÁP/ COMP]
TED · 447626-2026can-standardawardedNo deadline given
Value
Estimated€226,193 · 226,193.39 EUR
Awarded—
WinnerNOVARTIS FARMA - PROD.FARM SA
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 11 | — | 2026-06-09 |
| GILEAD SCIENCES, LDA | 10 | — | 2026-05-27 |
| AMGEN BIOFARMACEUTICA, LDA | 8 | €396,644 | 2026-06-24 |
| NOVARTIS FARMA - PROD.FARM SA | 8 | — | 2026-06-30 |
| TAKEDA-Farmaceuticos Portugal, Lda | 6 | €554,760 | 2026-06-24 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
RIBOCICLIB [200 MG CÁP/ COMP]
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-06-30 | 2023/0491 - RIBOCICLIB [200 MG CÁP/ COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 100% |
| 2026-06-30 | 2023/0491 - RUXOLITINIB [5 MG CÁP/ COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 97% |
| 2026-06-30 | 2023/0491 - RUXOLITINIB [5 MG CÁP/ COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 97% |
| 2026-06-24 | 2023/0491 - IBRUTINIB [420 MG CÁP/COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 97% |
| 2026-06-24 | 2023/0491 - ECULIZUMAB [300 MG SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-06-24 | 2023/0491 - ECULIZUMAB [300 MG SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
Records162,040 tendersNewest notice2026-07-03Last ingest2026-07-03 · TED daily 06:00Parser health (7d)all runs clean